Washington Dc, DCNCT06513156Now EnrollingIRB Ready

Opioid Use Disorder Clinical Trial in Washington Dc, DC

Access cutting-edge opioid use disorder treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by Elana Rosenthal

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access opioid use disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related opioid use disorder treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this opioid use disorder clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Opioid Use Disorder Study in Washington Dc

This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.

Sponsor: Elana Rosenthal

Who Can Participate

Inclusion Criteria

Age ≥ 18 years
Admitted to study hospital (defined as hospitalized with a primary team that is not Emergency Medicine)
Injection opioid or stimulant use in past 90 days - per patient self-report
Active suspected or confirmed qualifying infection (see list) at time of admission. Qualifying infections:
Non-vertebral osteomyelitis
Vertebral osteomyelitis or discitis
Epidural, subdural, or extradural abscess
Intracranial or intraspinal abscess
Native joint septic arthritis
Prosthetic joint septic arthritis
Blood stream infection (bacterial or fungal)
Native valve Endocarditis
Prosthetic valve endocarditis
Cardiac Implantable electronic device infection
Infectious pseudoaneurysm and aneurysm
Infected vascular graft
Septic venous thrombosis
Skin and Soft tissue infection (cellulitis, skin abscess, necrotizing fasciitis)
Infected skin ulcer
Orthopedic hardware infection
Muscle abscess/myositis
Central nervous system infection (bacterial or fungal)
Bacterial or fungal ophthalmologic infection
Other abscess
Pulmonary septic emboli
Other acute bacterial or fungal infection deemed appropriate by site study team

Exclusion Criteria

1\. Infection due to a cause other than injection drug use, per determination of a site PI. 2\. Inability to provide consent due to circumstance (e.g., sedated, intubated), language, or cognitive impairment. 3\. Unwilling to provide informed consent 4. Unable to receive potential interventions due to geography 5. On comfort measures or planned for discharge to hospice care 6. Incarcerated at the time of hospitalization 7. Other criteria at the discretion of the site investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT06513156) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Opioid Use Disorder Treatment Options in Washington Dc, DC

If you're searching for opioid use disorder treatment options in Washington Dc, DC, this clinical trial (NCT06513156) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all opioid use disorder clinical trials near you to find additional studies recruiting in your area.

More Substance Use Disorder Trials in Washington Dc, DC

See all substance use disorder clinical trials recruiting in Washington Dc — not just this study.

Browse Substance Use Disorder Trials in Washington Dc →

Browse More Trials by Condition

Substance Use Disorder TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC